Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://patents.google.com/patent/TWI627940B/en below:

TWI627940B - Physiological parameter monitoring system

Publication number

TWI627940B

TWI627940B TW106116270A TW106116270A TWI627940B TW I627940 B TWI627940 B TW I627940B TW 106116270 A TW106116270 A TW 106116270A TW 106116270 A TW106116270 A TW 106116270A TW I627940 B TWI627940 B TW I627940B

Authority

TW

Taiwan

Prior art keywords

server

physiological parameter

blood glucose

detecting device

value

Prior art date

2017-01-16

• Espacenet
• Global Dossier
• Discuss

• Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
• Measuring And Recording Apparatus For Diagnosis (AREA)

本發明提供一種生理參數監測系統，包含第一檢測裝置、第二檢測裝置及伺服器。該第一檢測裝置適於供個人使用並產生相關於使用者的多個第一生理參數資訊。該第二檢測裝置適於供醫療專業使用並產生一相關於使用者的第二生理參數資訊。該伺服器透過網路連接該第一檢測裝置與該第二檢測裝置，並分別從該第一檢測裝置與該第二檢測裝置接收該等第一生理參數資訊與該第二生理參數資訊，將其所有生理參數資訊整合於伺服器上進行數據管理分析。本發明還提供對應的應用軟體供使用者透過終端裝置存取分析數據。The invention provides a physiological parameter monitoring system, comprising a first detecting device, a second detecting device and a server. The first detection device is adapted for personal use and generates a plurality of first physiological parameter information relating to the user. The second detection device is adapted for use by a medical professional and generates a second physiological parameter information relating to the user. The server connects the first detecting device and the second detecting device through a network, and receives the first physiological parameter information and the second physiological parameter information from the first detecting device and the second detecting device respectively, All physiological parameter information is integrated on the server for data management analysis. The invention also provides a corresponding application software for the user to access the analysis data through the terminal device.

本發明是有關於一種生理參數監測系統，特別是指一種能整合供自我檢測的檢測裝置所檢測出的第一生理參數資訊，與供醫療專業使用的檢測裝置所檢測出的第二生理參數資訊的生理參數監測系統。The invention relates to a physiological parameter monitoring system, in particular to a first physiological parameter information which can be integrated by a detecting device for self-detection, and a second physiological parameter information detected by a detecting device used by a medical professional. Physiological parameter monitoring system.

除了血糖值管理之外，醣化血色素也是糖尿病患者重要的血糖控制指標。現有的供自我血糖檢測(self-monitoring of blood glucose)的血糖機雖然可讓糖尿病患者在餐前或餐後方便地自我檢測血糖值，但一般來說，其並無法檢測糖尿病患者的醣化血色素，糖尿病患者需要到醫療院所，並藉由供醫療專業使用的血糖機，例如現有的重點照護檢測器(Point-of-Care Testing, POCT)或是大型的生化儀，來檢測醣化血色素；因此，對需要定期追踪醣化血色素的糖尿病患者來說相當不便。In addition to blood glucose management, glycated hemoglobin is also an important indicator of glycemic control in diabetic patients. Existing blood glucose machines for self-monitoring of blood glucose allow diabetic patients to easily self-detect blood glucose levels before or after a meal, but in general, they cannot detect glycosylated hemoglobin in diabetic patients. Diabetic patients need to go to a medical institution and use a blood glucose machine for medical professionals, such as the existing Point-of-Care Testing (POCT) or a large biochemical analyzer to detect glycated hemoglobin; therefore, It is quite inconvenient for diabetic patients who need to track glycated hemoglobin regularly.

此外，雖然糖尿病患者可利用上述供自我血糖檢測的血糖機來自我檢測血糖值，但若缺乏針對所檢測出的血糖值的管理機制，糖尿病患者也不易記錄與觀察自身血糖值的變化。In addition, although diabetic patients can use the above-mentioned blood glucose meter for self-glycemic detection to detect blood sugar levels, in the absence of a management mechanism for the detected blood sugar level, it is difficult for diabetic patients to record and observe changes in their own blood glucose levels.

因此，本發明之目的，即在提供一種能方便使用者定期追踪醣化血色素值與血糖值的生理參數監測系統。Accordingly, it is an object of the present invention to provide a physiological parameter monitoring system that facilitates periodic tracking of glycated hemoglobin values and blood glucose levels by a user.

於是，本發明生理參數監測系統，包含一第一檢測裝置、一第二檢測裝置，及一伺服器。Therefore, the physiological parameter monitoring system of the present invention comprises a first detecting device, a second detecting device, and a server.

該第一檢測裝置適於供個人使用，並產生相關於一使用者的多個血糖值。The first detection device is adapted for personal use and produces a plurality of blood glucose values associated with a user.

該第二檢測裝置適於供醫療專業或醫療照護使用，並產生一相關於該使用者的醣化血色素量測值。The second detection device is adapted for use by a medical professional or medical care and produces a glycated hemoglobin measurement associated with the user.

該伺服器透過網路連接該第一檢測裝置與該第二檢測裝置，並從分別該第一檢測裝置與該第二檢測裝置接收該等血糖值與該醣化血色素量測值，且根據該等血糖值估計出一醣化血色素估計值，且輸出該醣化血色素量測值與該醣化血色素估計值。The server connects the first detecting device and the second detecting device through a network, and receives the blood sugar level and the glycated hemoglobin measurement value from the first detecting device and the second detecting device respectively, and according to the The glycemic value estimates a glycosylated hemoglobin estimate and outputs the glycated hemoglobin measurement and the glycated hemoglobin estimate.

本發明之功效在於：提供血糖值的統計分析與管理，方便使用者定期追踪醣化血色素值和血糖值。The invention has the advantages of providing statistical analysis and management of blood sugar levels, and facilitating users to regularly track glycated hemoglobin values and blood sugar levels.

參閱圖1，本發明生理參數監測系統1的一實施方式包含一第一檢測裝置22、一第一伺服器13，及位於醫療院所的一第二伺服器3、至少一工作站終端14與一第二檢測裝置12。該至少一工作站終端14連接該第二伺服器3，並可透過該第二伺服器3連接網際網路，位於醫療院所的一醫院管理系統(Health Information System) (圖1未示出)亦可連接該第二伺服器3，在一個實施例中，該第二伺服器3可以包含該醫院管理系統。在一個實施方式中，該生理參數監測系統1選擇性地包含一保險業者或健康服務提供者的伺服器6或/和其他授權裝置7，其中，該第一檢測裝置22及該第二檢測裝置12可以是用以監控生理參數或檢測疾病、健康、營養攝取、健身狀況或運動狀況的檢測裝置，該第一伺服器13、第一檢測裝置22、該工作站終端14及該第二檢測裝置12皆可透過網路傳輸資料，並可運行各自對應的一應用軟體以收集分析量測數據。其中該應用軟體可以是內建於裝置內，也可以自外部取得，如網路下載、透過網頁存取的雲端軟體等，但不限於此。Referring to FIG. 1 , an embodiment of the physiological parameter monitoring system 1 of the present invention includes a first detecting device 22 , a first server 13 , and a second server 3 located in the medical institution, at least one workstation terminal 14 and a Second detecting device 12. The at least one workstation terminal 14 is connected to the second server 3, and can be connected to the Internet through the second server 3. The Health Information System (not shown in FIG. 1) of the medical institution is also The second server 3 can be connected. In one embodiment, the second server 3 can include the hospital management system. In one embodiment, the physiological parameter monitoring system 1 optionally includes an insurer or health service provider server 6 or/and other authorization devices 7, wherein the first detection device 22 and the second detection device 12 may be a detecting device for monitoring physiological parameters or detecting disease, health, nutritional intake, fitness condition or exercise condition, the first server 13, the first detecting device 22, the workstation terminal 14 and the second detecting device 12 All data can be transmitted through the network, and each corresponding application software can be run to collect and analyze the measurement data. The application software may be built in the device or obtained from the outside, such as a network download, a cloud software accessed through a webpage, etc., but is not limited thereto.

運行於該第一檢測裝置22上的個人使用的一第一應用軟體(圖1未示出)可以將量測資料傳送至該第一伺服器13，選擇性地進行較繁複的分析運算，並將該量測資料傳回給該第一應用軟體，以及，該資料在經過使用者授權後，由該第一伺服器13傳送至該第二伺服器3，使得醫護人員可以透過該工作站終端14存取該第二伺服器3提供的一專業使用的第二應用軟體(圖1未示出)並用以根據該量測資料進行診斷。此外，該第二檢測裝置12所產生的量測資料傳送至該第二伺服器3或該第一伺服器13後，亦會傳送至該第一應用軟體及該第二應用軟體。在另一個實施方式中，該第一檢測裝置22及該第二檢測裝置12所量測的資料亦會傳送至位於醫療院所的該醫院管理系統進行儲存，作為病歷資料的使用。另一方面，當該醫護人員操作該第二應用軟體新增病患、操作人員或是其他項目時，可以透過該第二伺服器3將更新的項目傳送至該第二檢測裝置12的一後端管理軟體(圖1未示出)，使得該第二檢測裝置12可以依照醫囑或是工單設定操作人員或是被量測的對象。A first application software (not shown in FIG. 1) used by the individual running on the first detecting device 22 can transmit the measurement data to the first server 13, selectively performing a more complicated analysis operation, and The measurement data is transmitted back to the first application software, and the data is transmitted by the first server 13 to the second server 3 after being authorized by the user, so that the medical staff can pass through the workstation terminal 14 Accessing a professionally used second application software (not shown in FIG. 1) provided by the second server 3 and for performing diagnosis based on the measurement data. In addition, after the measurement data generated by the second detecting device 12 is transmitted to the second server 3 or the first server 13, the data is also transmitted to the first application software and the second application software. In another embodiment, the data measured by the first detecting device 22 and the second detecting device 12 are also transmitted to the hospital management system located in the medical institution for storage as medical record data. On the other hand, when the medical staff operates the second application software to add a patient, an operator, or other items, the updated item can be transmitted to the second detecting device 12 through the second server 3. The end management software (not shown in FIG. 1) allows the second detecting device 12 to set an operator or a measured object according to a doctor's order or a work order.

如圖1所示，在此該第一檢測裝置22包含一血糖檢測單元11與一行動裝置2。在另一個實施例中(圖1未示出)，該第一檢測裝置22可以是具有量測血糖功能的行動裝置，該量測功能可以透過內建或是外部連接至行動裝置的血糖量測模組實現，從而無須設置獨立的血糖檢測單元，其中該血糖量測模組可以透過一埠孔，如USB、音訊孔、藍芽、紅外線等方式外接於該行動裝置上。在另一個實施例中(圖1未示出)，該第一檢測裝置22可以是具有一網路傳輸功能的該血糖檢測單元11，該傳輸功能可以是內建或是外接至該第一檢測裝置22的一傳輸模組所實現，因此該血糖檢測單元11可包含血糖機以及行動裝置兩者所需的功能。以下用該第一檢測裝置22包含有該血糖檢測單元11與該行動裝置2的實施方式來做說明，其中該第一應用軟體安裝於該行動裝置2。As shown in FIG. 1, the first detecting device 22 includes a blood glucose detecting unit 11 and a mobile device 2. In another embodiment (not shown in FIG. 1), the first detecting device 22 can be a mobile device having a blood glucose measuring function, and the measuring function can measure blood glucose through a built-in or externally connected mobile device. The module is implemented, so that it is not necessary to provide an independent blood glucose detecting unit, wherein the blood glucose measuring module can be externally connected to the mobile device through a hole such as a USB, an audio hole, a Bluetooth, or an infrared. In another embodiment (not shown in FIG. 1), the first detecting device 22 can be the blood glucose detecting unit 11 having a network transmission function, and the transmitting function can be built-in or externally connected to the first detecting. A transmission module of device 22 is implemented such that the blood glucose detecting unit 11 can include the functions required by both the blood glucose meter and the mobile device. Hereinafter, the first detecting device 22 includes an embodiment in which the blood glucose detecting unit 11 and the mobile device 2 are included, wherein the first application software is installed in the mobile device 2.

該血糖檢測單元11為一供自我血糖檢測的血糖機，用於讓一使用者在餐前、餐後、起床、就寢，或其他時間量測自身的血糖值，並透過無線或有線網路通訊，例如WiFi、藍牙或USB等，將該血糖值與該血糖值對應的資料所形成的一數據序列傳送至該行動裝置2，其中該數據序列可以包含:事件標籤、紀錄序號、量測時間、量測時間對應的世界標準時間(Coordinated Universal Time, UTC)、量測日期、量測時區、血糖機型號、血糖機序號、使用者帳號、是否為品管液數值、量測溫度是否超標、資料類型(由第一檢測裝置或第二檢測裝置產生，或手動輸入)等，其中根據該資料類型可以判斷該筆血糖值來自哪個醫療院所，避免未來個人資料使用上的糾紛，而該行動裝置2可以是智慧型手機、穿戴式裝置或平板電腦等。在一個實施例中，該使用者可以操作該行動裝置2，手動將量測到的血糖值與對應的資料直接輸入至該行動裝置2。其中為防止該手動輸入的血糖會有輸入錯誤的可能，該第一應用軟體允許該使用者刪除該手動輸入的血糖值。The blood sugar detecting unit 11 is a blood glucose meter for self-blood glucose detection, which is used for allowing a user to measure his or her blood sugar level before, after, after, after, after going to bed, or at other times, and communicating through a wireless or wired network. For example, a data sequence formed by the data corresponding to the blood glucose level and the blood glucose level is transmitted to the mobile device 2, where the data sequence may include: an event tag, a record number, a measurement time, Measurement time corresponding to Coordinated Universal Time (UTC), measurement date, measurement time zone, blood glucose meter model, blood glucose meter serial number, user account number, whether it is the quality of the quality control fluid, whether the measured temperature exceeds the standard, and the data Type (generated by the first detecting device or the second detecting device, or manually input), etc., wherein according to the type of the data, it can be determined from which medical institution the blood glucose value comes from, and the dispute over the use of personal data in the future is avoided, and the mobile device 2 can be a smart phone, a wearable device or a tablet. In one embodiment, the user can operate the mobile device 2 to manually input the measured blood glucose value and the corresponding data directly to the mobile device 2. The first application software allows the user to delete the manually entered blood glucose level in order to prevent the input of the blood glucose from being input incorrectly.

另一方面，由於使用者可能因為出國旅遊或是洽公，該血糖檢測單元11無法自動依照使用者所在位置的時區進行調整時，必須手動進行調整，否則，血糖值依照量測時間的紀錄方面會遭遇不同時區上的困擾，進行血糖分析時會有不準確的問題。該生理參數監測系統1提供以下的解決方案來處理上述遇到的問題，請參閱圖2，首先，在步驟S21，該血糖檢測單元11與該行動裝置2透過無線或有線網路連接。接著在步驟S22，該行動裝置2將該行動裝置2上的當地時間傳送至該血糖檢測單元11，以設定該血糖檢測單元11的時鐘，使得該血糖檢測單元11的時間能夠與該行動裝置2維持同步，如此，即可避免因使用者移動到不同時區時，需要手動調整該血糖檢測單元11時間的問題。接著，在步驟S23，該血糖檢測單元11將該血糖值與該數據序列傳送至該行動裝置2的該第一應用軟體，其中該數據序列中的量測時間為當地時間，用以依照不同的事件，如進食、運動、用藥等進行配對。接著，在步驟S24，該第一應用軟體除了將包含有量測時間的數據序列儲存以外，也將該量測時間轉換成一UTC時間儲存，使得該血糖值能夠依照UTC時間進行排序，避免依照該量測時間(當地時間)進行血糖值排序時，無法呈現真實順序的問題，其中該UTC時間僅用於排序血糖值使用，可以選擇性地顯示在該第一應用軟體上。On the other hand, since the user may not be automatically adjusted according to the time zone of the user's location because the user may travel abroad or negotiate, the user must manually adjust the blood glucose value according to the measurement time. There will be troubles in different time zones, and there will be inaccuracies when performing blood glucose analysis. The physiological parameter monitoring system 1 provides the following solutions to deal with the problems encountered above. Referring to FIG. 2, first, in step S21, the blood glucose detecting unit 11 and the mobile device 2 are connected via a wireless or wired network. Next, in step S22, the mobile device 2 transmits the local time on the mobile device 2 to the blood glucose detecting unit 11 to set the clock of the blood glucose detecting unit 11 so that the time of the blood glucose detecting unit 11 can be combined with the mobile device 2 Synchronization is maintained, so that the problem of manually adjusting the time of the blood glucose detecting unit 11 when the user moves to a different time zone can be avoided. Next, in step S23, the blood glucose detecting unit 11 transmits the blood glucose value and the data sequence to the first application software of the mobile device 2, wherein the measurement time in the data sequence is local time, according to different Events, such as eating, exercising, medication, etc. Next, in step S24, the first application software converts the measurement time into a UTC time storage in addition to storing the data sequence including the measurement time, so that the blood glucose value can be sorted according to the UTC time, avoiding according to the When the measurement time (local time) is sorted by blood glucose values, the problem of the true order cannot be presented, wherein the UTC time is only used for sorting blood glucose values, and can be selectively displayed on the first application software.

舉例來說，請參閱圖3，該使用者或醫護人員操作該行動裝置2或該工作站終端14來執行該第一應用軟體或該第二應用軟體時，該行動裝置2或該工作站終端14的顯示畫面所顯示的該多筆血糖值係依照其各自對應的該量測的UTC時間進行排序，最上方為基於該量測的UTC時間中最新的血糖資料，依序往下排列，然而，顯示畫面顯示每筆血糖值對應的量測時間(當地時間)T，方便使用者查看血糖紀錄，因此，會出現量測時間(當地時間)較早的血糖值31排在量測時間(當地時間)較晚的血糖值32之前的情形。在一個實施方式中，該筆血糖值傳送至該行動裝置2時，該行動裝置2依據所在的經度及緯度，估計該筆血糖值所在的量測地區，並在該筆血糖值上顯示對應的國家，該國家的顯示方式可以是時區、國旗、國名或其組合。另一方面，請參閱圖4，該第一應用軟體及該第二應用軟體亦可以依照該量測時間(當地時間)T將該血糖值依據進食、運動、用藥等事件的發生前後進行配對，以形成一配對組合41，如圖4所示，該配對組合41為午餐前後的兩個血糖值的配對。For example, referring to FIG. 3, when the user or medical staff operates the mobile device 2 or the workstation terminal 14 to execute the first application software or the second application software, the mobile device 2 or the workstation terminal 14 The plurality of blood glucose values displayed on the display screen are sorted according to their respective measured UTC times, and the top is the latest blood glucose data based on the measured UTC time, sequentially arranged downward, however, the display The screen displays the measurement time (local time) T corresponding to each blood glucose level, which is convenient for the user to view the blood glucose record. Therefore, the measurement time (local time) will be earlier than the blood glucose level 31 in the measurement time (local time). The situation before the blood sugar level of 32 is later. In one embodiment, when the pen blood glucose value is transmitted to the mobile device 2, the mobile device 2 estimates the measurement region where the blood glucose level is located according to the longitude and latitude of the mobile device, and displays the corresponding blood glucose value. Country, the country can be displayed in the time zone, national flag, country name or a combination thereof. On the other hand, referring to FIG. 4, the first application software and the second application software may also pair the blood glucose values according to the measurement time (local time) T before and after the occurrence of events such as eating, exercising, and medication. To form a pairing combination 41, as shown in FIG. 4, the pairing combination 41 is a pairing of two blood glucose values before and after lunch.

此外，在一個實施方式中，該使用者操作該行動裝置2透過網際網路將該血糖值傳送至該第一伺服器13後，當醫療院所有診斷上的需求時，該醫療院所可以發起請求，以請求使用者授權該醫療院所使用該傳送至第一伺服器13的量測資料。請參閱圖5，首先，在步驟S51，醫護人員透過該工作終端14存取該第二伺服器3所提供的該第二應用軟體而向該第一伺服器13發出一授權請求。接著，在步驟S52，該第一伺服器13將授權碼透過簡訊傳送至該行動裝置2，但不限於此，也可為其他授權方式。在步驟S53，該使用者可以決定是否願意授權該醫療院所使用個人量測資料。若該使用者願意授權時，在步驟S54，使用者將授權碼提供給醫護人員，醫護人員再操作該工作站終端14將使用者提供的授權碼輸入至位於該醫療院所的該第二伺服器3所提供的的第二應用軟體。在步驟S55，位於該醫療院所的該第二伺服器3向第一伺服器13驗證在步驟S54所收到的授權碼。在步驟S56，當該第一伺服器13通知該第二伺服器3通過驗證時，在步驟S57，該醫療院所即可獲得該使用者授權使用個人資料及測試數據，若在步驟S53，使用者不同意授權，或是在步驟S56，該驗證未通過時，該醫療院所皆無法取得使用者的授權，因而無法使用該使用者的個人量測資料。除了透過簡訊傳送授權碼外，在另一個實施方式中，該第一伺服器13可以透過發送一通知訊息至該行動裝置2，供使用者選擇是否同意授權。在一個實施例方式中，該行動裝置2可以列出欲授權的對象，讓使用者選擇同意授權的對象，其中該對象不限於醫療院所，可以是保險公司、藥局或其他健康服務提供者6，但不限於此。透過使用者授權的方式，該生理參數監測系統1可以有效保障使用者個人醫療資訊的隱私權。另一方面，當使用者欲退出本系統所提供的服務時，可以操作該第一應用軟體，以傳送一刪除指令至該第一伺服器13，刪除該名使用者傳送至該第一伺服器13上的所有資料，而該第一伺服器13再傳送一通知訊息至該第二伺服器3，通知該授權的醫療院所刪除該名使用者傳送至該第二伺服器3的資料。In addition, in an embodiment, after the user operates the mobile device 2 to transmit the blood glucose value to the first server 13 through the Internet, the medical institution can initiate the medical institution when all the medical requirements are required. A request is made to request the user to authorize the medical institution to use the measurement data transmitted to the first server 13. Referring to FIG. 5, first, in step S51, the medical staff accesses the second application software provided by the second server 3 through the working terminal 14 to issue an authorization request to the first server 13. Next, in step S52, the first server 13 transmits the authorization code to the mobile device 2 through the short message, but is not limited thereto, and may be other authorization methods. At step S53, the user can decide whether or not they are willing to authorize the personal measurement data used by the hospital. If the user is willing to authorize, in step S54, the user provides the authorization code to the medical staff, and the medical staff operates the workstation terminal 14 to input the authorization code provided by the user to the second server located in the medical institution. 3 second application software provided. At step S55, the second server 3 located at the medical institution verifies the authorization code received at step S54 to the first server 13. In step S56, when the first server 13 notifies the second server 3 to pass the verification, in step S57, the medical institution can obtain the user authorized use of personal data and test data, if used in step S53, The user does not agree with the authorization, or in step S56, when the verification fails, the medical institution cannot obtain the authorization of the user, and thus the personal measurement data of the user cannot be used. In addition to transmitting the authorization code through the short message, in another embodiment, the first server 13 can send a notification message to the mobile device 2 for the user to select whether to approve the authorization. In an embodiment, the mobile device 2 may list the object to be authorized, and let the user select the object of consenting to the authorization, wherein the object is not limited to the medical institution, and may be an insurance company, a pharmacy, or another health service provider. 6, but not limited to this. The physiological parameter monitoring system 1 can effectively protect the privacy of the user's personal medical information by means of user authorization. On the other hand, when the user wants to quit the service provided by the system, the first application software can be operated to transmit a delete command to the first server 13, and the user is deleted and transmitted to the first server. The first server 13 transmits a notification message to the second server 3 to notify the authorized medical institution to delete the data transmitted by the user to the second server 3.

該第二檢測裝置12為一供醫療專業使用的血糖機，例如現有的重點照護檢測器Rightest ^®GM700 Pro 或/和其他生化儀，適於設置在該醫療院所，並藉由該後端管理軟體管理該第二檢測裝置12所需的品質管理、群組化管理、分析圖表產出、銜接醫院醫囑系統等功能，並可連接至位於該醫療院所的該第二伺服器3。在該使用者前往該醫療院所就診時，藉由該第二檢測裝置12量測該使用者的一醣化血色素量測值及血糖值，並透過該第二伺服器3將該醣化血色素量測值及血糖值傳送給該第一伺服器13，其中由於該使用者已經授權該醫療院所使用個人的量測資料，因此，在該第二檢測裝置12透過該第二伺服器3傳送量測資料至該第一伺服器13時不需要使用者的授權。在另一個實施方式中，醫護人員自各個科室的工作站終端14手動輸入至該第二應用軟體，以將該醣化血色素量測值透過該第二伺服器3經由網路傳送至該第一伺服器13。在一個實施方式中，該第二檢測裝置12透過網路直接連接該第一伺服器13，使得使用者在該醫療院所透過該第二檢測裝置12所量測的資料可由該第二檢測裝置12直接上傳至該第一伺服器13，其中該工作站終端14可以是桌上型電腦、筆記型電腦、平板電腦、智慧型手機等運算裝置，但不限於此。 The second detecting device 12 is a blood glucose meter for medical professionals, such as the existing key care detector Righttest ^® GM700 Pro or/and other biochemical analyzers, which are suitable for setting in the medical institution and managed by the back end. The software manages the functions of quality management, group management, analysis of chart output, connection to the hospital order system, and the like, and can be connected to the second server 3 located in the medical institution. When the user visits the medical institution, the second detecting device 12 measures the glycated hemoglobin measurement value and the blood sugar level of the user, and measures the glycated hemoglobin through the second server 3. The value and the blood glucose value are transmitted to the first server 13, wherein the second detecting device 12 transmits the measurement through the second server 3 because the user has authorized the measurement data of the individual used by the medical institution. The user's authorization is not required when the data is sent to the first server 13. In another embodiment, the medical staff manually inputs to the second application software from the workstation terminal 14 of each department to transmit the glycated hemoglobin measurement value to the first server via the network through the second server 3. 13. In an embodiment, the second detecting device 12 is directly connected to the first server 13 through a network, so that the data measured by the user in the medical institution through the second detecting device 12 can be used by the second detecting device. 12 is directly uploaded to the first server 13, wherein the workstation terminal 14 may be an arithmetic device such as a desktop computer, a notebook computer, a tablet computer, a smart phone, etc., but is not limited thereto.

該第一伺服器13或該第二伺服器3根據在一時間區間內該使用者利用該血糖檢測單元11或該第二檢測裝置12所量測到的多個血糖值，估計出一醣化血色素估計值(Est. HbA1c)，並將該醣化血色素量測值與該醣化血色素估計值輸出至該行動裝置2的該第一應用軟體及該第二伺服器3提供的該第二應用軟體；如此，除了可以讓該使用者透過該行動裝置2看到在該醫療院所量測到的該醣化血色素量測值，還可藉由觀察該醣化血色素估計值來自行追踪醣化血色素的變化，相同地，經過使用者授權同意後，醫護人員亦可透過該工作站終端14查看並分析該使用者透過該血糖檢測單元11及該第二檢測裝置12量測產出的所有數值，得以全面性的評估該使用者的健康狀況。於上述實施例中，若以血糖控制來說，醣化血色素為重要關鍵指標，於其他實施例中，也可置換或增加不同指標物質以全面評估使用者的健康狀況。The first server 13 or the second server 3 estimates a glycated hemoglobin based on a plurality of blood glucose values measured by the user using the blood glucose detecting unit 11 or the second detecting device 12 in a time interval. Estimating the value (Est. HbA1c), and outputting the glycated hemoglobin measurement value and the glycated hemoglobin estimation value to the first application software of the mobile device 2 and the second application software provided by the second server 3; In addition to allowing the user to see the measured amount of glycated hemoglobin measured at the medical institution through the mobile device 2, the glycated hemoglobin measurement can also be traced by observing the glycated hemoglobin estimate, and the same After being authorized by the user, the medical staff can also view and analyze all the values measured by the user through the blood glucose detecting unit 11 and the second detecting device 12 through the workstation terminal 14, so that the comprehensive evaluation can be performed. The health of the user. In the above embodiment, if glycated hemoglobin is an important key indicator in terms of blood glucose control, in other embodiments, different indicator substances may be replaced or added to comprehensively evaluate the user's health condition.

在本實施例中，該第一伺服器13計算出在該時間區間內的該等血糖值的一平均值，並根據該平均值計算出該醣化血色素估計值，也就是： 醣化血色素估計值=(血糖平均值+第一參數)/第二參數， 較佳地，該第一參數為43~48之間的一數值，且該第二參數為25~30之間的一數值。In this embodiment, the first server 13 calculates an average value of the blood glucose values in the time interval, and calculates the glycated hemoglobin estimation value based on the average value, that is, the glycated hemoglobin estimation value= (blood glucose average + first parameter) / second parameter, preferably, the first parameter is a value between 43 and 48, and the second parameter is a value between 25 and 30.

舉例來說，參閱圖6，圖6示意該使用者操作該行動裝置2或是醫護人員操作該工作站終端14，運行對應的應用軟體後在該行動裝置2或該工作站終端14所看到的醣化血色素量測值、利用該血糖檢測單元11或該第二檢測裝置12所量測到的血糖值，及醣化血色素估計值(Est. HbA1c)等資訊。其中，該使用者每隔三個月去該醫療院所就診並分別在2016/1/1與2016/4/1在該醫療院所利用該第二檢測裝置12量測到該醣化血色素量測值為6.6%與6.3%，當醫護人員點選其中一筆醣化血色素量測值的欄位時，該應用軟體會呈現該筆醣化血色素量測值的量測時間往前推一區間內的自我量測血糖值，例如90天內的所有血糖值，舉例來說，點選該2016/1/1所量測的醣化血色素量測值的欄位時，右邊的血糖值列表會顯示2016/1/1往前推90天內的所有血糖值，供醫護人員作為診斷該醣化血色素量測值的輔助參考工具。該應用軟體以七日為該時間區間，每隔七日根據該血糖檢測單元11或該第二檢測裝置12在該七日內所量測到的所有血糖值計算出一對應的醣化血色素估計值。For example, referring to FIG. 6, FIG. 6 illustrates the saccharification seen by the user operating the mobile device 2 or the medical staff operating the workstation terminal 14 after running the corresponding application software at the mobile device 2 or the workstation terminal 14. The hemoglobin measurement value, the blood glucose level measured by the blood sugar detecting unit 11 or the second detecting device 12, and the glycated hemoglobin estimated value (Est. HbA1c) and the like. The user visits the medical institution every three months and measures the glycated hemoglobin measurement by using the second detecting device 12 at the medical institution at 2016/1/1 and 2016/4/1, respectively. The values are 6.6% and 6.3%. When the medical staff selects one of the fields of glycosylated hemoglobin measurement, the application software will display the measurement time of the glycated hemoglobin measurement value and push the self-quantity within a certain interval. Measure blood glucose levels, such as all blood glucose values for 90 days. For example, when you select the field for the measured glycated hemoglobin measurement measured in 2016/1/1, the list of blood glucose values on the right will display 2016/1/ 1 Push forward all blood glucose values for 90 days for medical staff to use as an auxiliary reference tool for diagnosing the glycated hemoglobin measurement. The application software calculates the corresponding glycated hemoglobin estimation value based on all the blood glucose values measured by the blood glucose detecting unit 11 or the second detecting device 12 during the seven days for the seven-day period.

如圖6所示，該使用者在2016/4/1～2016/4/7期間共利用該血糖檢測單元11或該第二檢測裝置12共量測了15次血糖值，且在2016/4/8～2016/4/14期間共利用該血糖檢測單元11或該第二檢測裝置12共量測了32次血糖值；而該第一伺服器13根據該15筆血糖值所估計出的醣化血色素估計值為6.1%，且根據該32筆血糖值所估計出的醣化血色素估計值為5.7%。由上述可知，雖然該使用者每隔三個月才在該醫療院所量測一次該醣化血色素量測值，但藉由本發明生理參數監測系統1，該使用者能方便地藉由觀察每週的醣化血色素估計值來追踪自身醣化血色素的變化，當該醣化血色素估計值與該醣化血色素量測值差距超過一門檻值時，該第一應用軟體或該第二應用軟體還可輸出一警示訊息，當使用者發現醣化血色素有異常的變化，便可即時就醫，其中，該門檻值可以是1.5%~3%之間的一數值；而即使醣化血色素沒有異常的變化，該等醣化血色素估計值也可在就醫時供醫生參考。另一方面，在一個實施方式中，該第一檢測裝置22使用該血糖檢測單元11所量測的血糖值，經由該行動裝置2上的第一應用軟體估計出該醣化血色素估計值，而無需交由該第一伺服器13進行運算，即可自行追踪醣化血色素的變化。此外，該時間區間並不以七日為限，也可為14日、30日，或其他天數。As shown in FIG. 6 , the user commonly used the blood glucose detecting unit 11 or the second detecting device 12 to measure the blood glucose level 15 times during the period from 2016/4/1 to 2016/4/7, and in 2016/4. The blood glucose detecting unit 11 or the second detecting device 12 collectively measured the blood glucose level 32 times during the period from 8/2016 to 4/14; and the first server 13 estimates the saccharification based on the 15 blood glucose levels. The estimated hemoglobin was 6.1%, and the estimated glycated hemoglobin based on the 32 blood glucose values was 5.7%. It can be seen from the above that although the user measures the glycated hemoglobin measurement value in the medical institution every three months, the user can conveniently observe the weekly by the physiological parameter monitoring system 1 of the present invention. The glycated hemoglobin estimate is used to track the change of the glycated hemoglobin. When the difference between the estimated glycated hemoglobin and the glycated hemoglobin measurement exceeds a threshold, the first application software or the second application software can also output a warning message. When the user finds abnormal changes in glycated hemoglobin, he can immediately seek medical treatment, wherein the threshold value can be a value between 1.5% and 3%; and even if there is no abnormal change in glycated hemoglobin, the glycated hemoglobin estimates It can also be consulted by doctors when you seek medical attention. On the other hand, in one embodiment, the first detecting device 22 estimates the glycated hemoglobin estimation value via the first application software on the mobile device 2 using the blood glucose level measured by the blood glucose detecting unit 11 without By performing the calculation by the first server 13, the change of the glycated hemoglobin can be traced by itself. In addition, the time interval is not limited to seven days, but may be 14 days, 30 days, or other days.

除了針對醣化血色素的估計與管理之外，本發明生理參數監測系統1還進一步提供針對血糖值的統計分析與管理。詳言之，該第一伺服器13根據在該時間區間內，從該血糖檢測單元11或該第二檢測裝置12接收到的該等血糖值計算出在該時間區間內該等血糖值的一平均值與一標準差。當該標準差大於該平均值的一第一倍數時，該第一伺服器13還輸出一用於指示「波動過大」的資訊；當該標準差小於該平均值的一第二倍數時，該第一伺服器13還輸出一用於指示「波動理想」的資訊；而當該標準差大於該平均值的該第二倍數且小於該平均值的該第一倍數時，該第一伺服器13還輸出一用於指示「波動較大」的資訊；其中該第一倍數大於該第二倍數，且較佳地，分別為0.2~1之間的一數值與0.1~0.7之間的一數值，或較佳地，分別為0.3~0.6之間的一數值與0.2~0.4之間的一數值。In addition to the estimation and management of glycated hemoglobin, the physiological parameter monitoring system 1 of the present invention further provides statistical analysis and management of blood glucose levels. In detail, the first server 13 calculates one of the blood glucose levels in the time interval based on the blood glucose values received from the blood glucose detecting unit 11 or the second detecting device 12 during the time interval. The average is one standard deviation. When the standard deviation is greater than a first multiple of the average value, the first server 13 further outputs a message for indicating "fluctuation is too large"; when the standard deviation is less than a second multiple of the average value, the The first server 13 also outputs a message for indicating "fluctuation ideal"; and when the standard deviation is greater than the second multiple of the average value and less than the first multiple of the average value, the first server 13 And outputting a message for indicating "large fluctuation"; wherein the first multiple is greater than the second multiple, and preferably, a value between 0.2 and 1 and a value between 0.1 and 0.7, respectively. Or preferably, a value between 0.3 and 0.6 and a value between 0.2 and 0.4, respectively.

舉例來說，參閱圖7~9，其示意該使用者操作該行動裝置2、醫護人員操作之該工作站終端14或在該生理參數監測系統1中經過授權的授權裝置7連線該第一伺服器13，運行各自對應的應用軟體後，該終端或裝置的螢幕上所顯示的血糖值的相關管理資訊；特別地，是以直向長條圖4和包含橫向長條圖51的訊息方塊5來顯示統計分析結果。For example, referring to FIGS. 7-9, the user operates the mobile device 2, the workstation terminal 14 operated by the medical staff, or the authorized authorization device 7 in the physiological parameter monitoring system 1 to connect the first servo. The management information related to the blood glucose level displayed on the screen of the terminal or device after running the corresponding application software; in particular, the straight bar graph 4 and the message block 5 including the horizontal bar graph 51 To display statistical analysis results.

舉例來說，如圖7所示，該使用者在2016/4/23~2016/4/29期間的早餐餐後所量測到的血糖值對應的長條圖顯示血糖平均值為197 mg/dL且標準差為51.6，其中該長條圖的高度對應該血糖平均值，該長條圖內有顏色填充的部分的高度則對應該標準差；特別地，因為51.6小於197的第二倍數，所以在該長條圖中以綠色部分(以點圖表示)的高度來表示51.6，以指示血糖值的波動理想。該使用者在2016/4/16~2016/4/22期間的午餐餐後所量測到的血糖值對應的長條圖顯示血糖平均值為193 mg/dL且標準差為80.5；因為80.5大於193的第二倍數且小於193的第一倍數，所以在該長條圖中以橘色部分(以L型圖表示)的高度來表示80.5，以指示血糖值的波動較大。此外，雖然圖7中未繪示，若血糖值的波動過大，長條圖中則會以紅色來表示大於平均值的第一倍數的標準差；且雖然在此是分別以綠色、橘色、紅色來表示血糖值的波動理想、血糖值的波動較大、血糖值的波動過大，但並不以此為限，顏色、外型或設計的選擇只要能區分出上述的三種波動情況即可，於波動情況計算期間也可調整為按周/月/年/或其他天數進行計算。For example, as shown in FIG. 7, the bar graph corresponding to the blood glucose level measured by the user after the breakfast meal during the period of 2016/4/23~2016/4/29 shows that the average blood glucose level is 197 mg/ dL and the standard deviation is 51.6, wherein the height of the bar graph corresponds to the average value of blood glucose, and the height of the portion with color filling in the bar graph corresponds to the standard deviation; in particular, because 51.6 is less than the second multiple of 197, Therefore, in the bar graph, the height of the green portion (indicated by the dot plot) is expressed as 51.6 to indicate that the fluctuation of the blood glucose level is ideal. The long bar graph corresponding to the blood glucose level measured by the user after the lunch meal during the period of 2016/4/16~2016/4/22 shows that the average blood glucose level is 193 mg/dL and the standard deviation is 80.5; The second multiple of 193 is less than the first multiple of 193, so 80.5 is indicated by the height of the orange portion (indicated by the L-shaped diagram) in the bar graph to indicate that the fluctuation of the blood glucose level is large. In addition, although not shown in FIG. 7, if the fluctuation of the blood glucose level is too large, the standard deviation of the first multiple of the average value is represented by red in the bar graph; and although it is respectively green, orange, Red indicates that the fluctuation of blood sugar value is ideal, the fluctuation of blood sugar level is large, and the fluctuation of blood sugar level is too large, but it is not limited to this. The choice of color, appearance or design can be distinguished by the above three fluctuations. It can also be adjusted to calculate by week/month/year/or other days during the calculation of the fluctuations.

參閱圖8與圖9，當該使用者透過該行動裝置2或醫護人員操作該工作站終端14各自對應的應用軟體，並點選直向長條圖4時，該應用軟體進一步顯示一包含血糖筆數、波動情況，及橫向長條圖51等資訊的訊息方塊5。特別地，該橫向長條圖51的兩端與內部分別顯示了所對應該等血糖值的最低值、最高值，及平均值；其中該橫向長條圖51的紅色部分(以+型圖表示)代表血糖值過高的筆數佔所有血糖筆數的佔比範圍、灰色部分代表血糖值正常的筆數佔所有血糖筆數的佔比範圍，且藍色部分(以△型圖表示)代表血糖值過低的筆數佔所有血糖筆數的佔比範圍。Referring to FIG. 8 and FIG. 9, when the user operates the corresponding application software of the workstation terminal 14 through the mobile device 2 or the medical staff, and selects the straight bar graph 4, the application software further displays a blood glucose pen. Message block 5 of information such as number, fluctuation, and horizontal bar graph 51. Specifically, the two ends of the horizontal bar graph 51 respectively display the lowest value, the highest value, and the average value of the corresponding blood sugar level; wherein the red portion of the horizontal bar graph 51 is represented by a + type diagram ) The number of pens that represent too high a blood sugar level accounts for the proportion of all blood glucose pens, the gray part represents the normal number of blood glucose values, and the blue part (represented by a Δ-type graph) The number of pens with low blood sugar levels accounts for the proportion of all blood glucose pens.

舉例來說，如圖8所示，當該使用者透過該行動裝置2或是醫護人員操作該工作站終端14各自對應的應用軟體並點選直向長條圖4a時，所顯示的訊息方塊5說明了在2016/4/23~2016/4/29期間的早餐餐後的血糖值共有七筆，該等血糖值的最低值、最高值及平均值分別為111、272及197 mg/dL，且雖然該等血糖值的波動理想，但仍有部分血糖值過高的情況，顯示其係在多數血糖值過高的情況下波動理想。如圖9所示，當該使用者或是醫護人員點選直向長條圖4b時，所顯示的訊息方塊5說明了在2016/4/23~2016/4/29期間的午餐餐後的血糖值共有3筆，該等血糖值的最低值、最高值及平均值分別為89、114及102 mg/dL，且雖然該等血糖值的波動理想，但仍有部分血糖值過低的情況，顯示其係在多數血糖值偏低的情況下波動理想，因此透過生理參數監測系統1跳出訊息框5以顯示血糖波動情況及其他統計分析結果，可以提供使用者簡易且迅速監控血糖趨勢，提早預防病情惡化。For example, as shown in FIG. 8, when the user operates the corresponding application software of the workstation terminal 14 through the mobile device 2 or the medical staff member and selects the straight bar graph 4a, the displayed message block 5 It shows that there are seven blood glucose values after breakfast meal in 2016/4/23~2016/4/29. The lowest, highest and average values of these blood glucose values are 111, 272 and 197 mg/dL, respectively. And although the fluctuation of these blood glucose values is ideal, there are still some cases where the blood glucose level is too high, indicating that it is ideal for fluctuations in the case where most blood glucose levels are too high. As shown in Figure 9, when the user or medical staff clicks on the straight bar graph 4b, the displayed message box 5 indicates the lunch after the 2016/4/23~2016/4/29 period. There are 3 blood glucose levels. The lowest, highest and average values of these blood glucose values are 89, 114 and 102 mg/dL, respectively. Although the fluctuation of these blood glucose values is ideal, some blood glucose values are still too low. It shows that it is ideal for fluctuations in most cases where the blood glucose level is low. Therefore, the physiological parameter monitoring system 1 jumps out of the message box 5 to display the blood glucose fluctuation and other statistical analysis results, which can provide the user with simple and rapid monitoring of the blood sugar trend, early Prevent the disease from getting worse.

參閱圖10，其顯示一名使用者在使用該生理參數監測系統後所累積的血糖管理資訊，透過本發明生理參數監測系統的使用，藉由使用者量測資訊分析技術及視覺化圖表，有利於醫生方便識別病人血糖管理狀況，更能協助醫生進行有效診斷，如圖10所示，其中由下至上顯示了較舊至較新的資料，從中可以觀察到，在該名使用者使用生理參數監測系統進行診斷後，在有效的工具輔助下，其所顯示的直向長條圖4c、4d從指示血糖值「波動過大」的紅色(以+型圖表示)隨著時間經過慢慢朝血糖值「波動理想」的綠色(以點圖表示)進步，因此該生理參數監測系統藉由將血糖值以配對組合的方式呈現，且將醣化血色素量測值與估計值並列進行比較，做為診斷的參考，以及藉由血糖值所計算之平均值與標準差的圖表呈現血糖的波動，提供一個可以協助使用者有效控制血糖的方法。Referring to FIG. 10, it shows the blood glucose management information accumulated by a user after using the physiological parameter monitoring system. Through the use of the physiological parameter monitoring system of the present invention, the user measures information analysis technology and visualizes the chart. The doctor can easily identify the patient's blood glucose management status, and can assist the doctor to make an effective diagnosis, as shown in Figure 10. The bottom to the top shows the older to newer data, from which it can be observed that the user uses the physiological parameters. After the monitoring system performs the diagnosis, with the aid of the effective tool, the straight bar graphs 4c and 4d displayed from the red (indicated by the +-type graph) indicating the blood glucose value "over-fluctuation" slowly progress toward the blood glucose over time. The green value of the "fluctuation ideal" progresses (indicated by a dot plot), so the physiological parameter monitoring system presents the blood glucose values in a paired combination, and compares the measured glycated hemoglobin measurement with the estimated value as a diagnosis. Reference, and a graph of the mean and standard deviation calculated by blood glucose values to present fluctuations in blood glucose, providing a means to assist the user in effectively controlling blood The method of sugar.

綜上所述，本發明生理參數監測系統，藉由該血糖檢測單元產生相關於使用者的血糖值，該第二檢測裝置產生相關於使用者的醣化血色素量測值與血糖值，該第一伺服器或該第二伺服器根據血糖值估計出醣化血色素估計值，且輸出醣化血色素量測值、醣化血色素估計值，及血糖值給行動裝置，並進一步提供血糖值的統計分析與管理，能方便使用者定期追踪醣化血色素值與血糖值的變化，故確實能達成本發明的目的。In summary, the physiological parameter monitoring system of the present invention generates a blood glucose level related to a user by the blood glucose detecting unit, and the second detecting device generates a glycated hemoglobin measurement value and a blood sugar level related to the user, the first The server or the second server estimates the glycated hemoglobin estimation value according to the blood sugar level, and outputs the glycated hemoglobin measurement value, the glycated hemoglobin estimation value, and the blood sugar level to the mobile device, and further provides statistical analysis and management of the blood glucose value, and can It is convenient for the user to regularly track changes in the glycated hemoglobin value and the blood sugar level, so that the object of the present invention can be achieved.

惟以上所述者，僅為本發明的實施例而已，當不能以此限定本發明實施的範圍，凡是依本發明申請專利範圍及專利說明書內容所作的簡單的等效變化與修飾，皆仍屬本發明專利涵蓋的範圍內。However, the above is only the embodiment of the present invention, and the scope of the invention is not limited thereto, and all the simple equivalent changes and modifications according to the scope of the patent application and the patent specification of the present invention are still Within the scope of the invention patent.

1‧‧‧生理參數監測系統
11‧‧‧血糖檢測單元
12‧‧‧第二檢測裝置
13‧‧‧第一伺服器
14‧‧‧工作站終端
2‧‧‧行動裝置
22‧‧‧第一檢測裝置
3‧‧‧第二伺服器
4‧‧‧直向長條圖
4a~4d‧‧‧直向長條圖
5‧‧‧訊息方塊
51‧‧‧橫向長條圖
6‧‧‧伺服器
7‧‧‧授權裝置1‧‧‧ Physiological parameter monitoring system
11‧‧‧ Blood glucose testing unit
12‧‧‧Second detection device
13‧‧‧First server
14‧‧‧Workstation terminal
2‧‧‧Mobile devices
22‧‧‧First detection device
3‧‧‧Second server
4‧‧‧ Straight bar chart
4a~4d‧‧‧ Straight bar chart
5‧‧‧ message box
51‧‧‧ horizontal bar chart
6‧‧‧Server
7‧‧‧Authorized device

本發明的其他的特徵及功效，將於參照圖式的實施方式中清楚地呈現，其中： 圖1是一示意圖，說明本發明生理參數監測系統的一實施例； 圖2是一流程圖，說明一血糖檢測單元傳送一血糖值及對應的一數據序列給一行動裝置的方式； 圖3是一顯示畫面，顯示經排序後的多筆血糖值； 圖4是一顯示畫面，顯示多筆血糖值的配對組合； 圖5是一流程圖，說明醫療院所自該第一檢測裝置取得授權的步驟； 圖6是一示意圖，說明在一行動裝置上顯示血糖值、醣化血色素量測值、醣化血色素估計值等資訊； 圖7是一示意圖，說明在該行動裝置上顯示血糖值的多個直向長條圖； 圖8是一示意圖，說明在該行動裝置上顯示血糖值的一訊息方塊； 圖9是一示意圖，說明在該行動裝置上顯示血糖值的另一訊息方塊；及 圖10是一顯示畫面示意圖，顯示經排序後的多組血糖值。Other features and advantages of the present invention will be apparent from the embodiments of the present invention, wherein: FIG. 1 is a schematic diagram illustrating an embodiment of the physiological parameter monitoring system of the present invention; FIG. 2 is a flow chart illustrating A blood glucose detecting unit transmits a blood glucose level and a corresponding data sequence to a mobile device; FIG. 3 is a display screen showing the plurality of sorted blood glucose levels; FIG. 4 is a display screen displaying multiple blood glucose levels Figure 5 is a flow chart illustrating the steps taken by the medical institution to obtain authorization from the first detecting device; Figure 6 is a schematic view showing the display of blood sugar level, glycated hemoglobin measurement value, glycated hemoglobin on a mobile device Figure 7 is a schematic diagram showing a plurality of straight bar graphs showing blood glucose levels on the mobile device; FIG. 8 is a schematic diagram showing a message block displaying blood glucose values on the mobile device; 9 is a schematic diagram illustrating another message block for displaying a blood glucose level on the mobile device; and FIG. 10 is a schematic diagram showing a plurality of sets of blood glucose values after sorting

一種生理參數監測系統，包含： 一第一檢測裝置，適於供個人使用，並產生相關於一使用者的多個第一生理參數； 一第二檢測裝置，適於供醫療專業使用，並產生一相關於該使用者的第二生理參數；及 一第一伺服器，透過網路連接該第一檢測裝置及該第二檢測裝置，並分別從該第一檢測裝置與該第二檢測裝置接收該等第一生理參數與該第二生理參數，其中該等第一生理參數及該第二生理參數相關於該使用者的疾病、健康、營養攝取、健身或運動的狀態或情況。A physiological parameter monitoring system comprising: a first detecting device adapted for personal use and generating a plurality of first physiological parameters related to a user; a second detecting device adapted for use by a medical professional and generating a second physiological parameter related to the user; and a first server, connecting the first detecting device and the second detecting device through a network, and receiving respectively from the first detecting device and the second detecting device The first physiological parameter and the second physiological parameter, wherein the first physiological parameter and the second physiological parameter are related to a state or condition of the user's disease, health, nutritional intake, fitness or exercise. 如請求項1所述的生理參數監測系統，其中，每一第一生理參數為血糖值，且該第二生理參數為醣化血色素量測值。The physiological parameter monitoring system of claim 1, wherein each first physiological parameter is a blood glucose level, and the second physiological parameter is a glycated hemoglobin measurement. 如請求項2所述的生理參數監測系統，其中，該第一伺服器根據該等血糖值估計出一醣化血色素估計值，且輸出該醣化血色素量測值與該醣化血色素估計值。The physiological parameter monitoring system according to claim 2, wherein the first server estimates a glycated hemoglobin estimation value based on the blood glucose levels, and outputs the glycated hemoglobin measurement value and the glycated hemoglobin estimation value. 如請求項1所述的生理參數監測系統，更包含一第二伺服器，其中該第二伺服器設置於醫療院所內，該第二伺服器執行一用於自該第一檢測裝置取得授權的方法，該方法包括以下步驟: (a) 該第二伺服器發送一授權請求至該第一伺服器； (b) 該第一伺服器發送一授權訊息至該第一檢測裝置； (c) 該第二伺服器經由一相關於該第一檢測裝置的使用者的輸入而接收到該授權訊息； (d) 該第二伺服器向該第一伺服器驗證該授權訊息；及 (e) 當該步驟(d)的驗證結果為肯定時，該第二伺服器取得授權。The physiological parameter monitoring system of claim 1, further comprising a second server, wherein the second server is disposed in the medical institution, and the second server executes a function for obtaining authorization from the first detecting device The method includes the following steps: (a) the second server sends an authorization request to the first server; (b) the first server sends an authorization message to the first detecting device; (c) The second server receives the authorization message via an input of a user associated with the first detecting device; (d) the second server verifies the authorization message to the first server; and (e) When the verification result of the step (d) is affirmative, the second server obtains the authorization. 如請求項4所述的生理參數監測系統，其中，在該步驟(b)，該授權訊息為一授權碼或一授權通知。The physiological parameter monitoring system of claim 4, wherein in the step (b), the authorization message is an authorization code or an authorization notification. 如請求項4所述的生理參數監測系統，其中，在該步驟(b)，該第一伺服器透過網路發送該授權訊息。The physiological parameter monitoring system of claim 4, wherein in the step (b), the first server transmits the authorization message via the network. 如請求項3所述的生理參數監測系統，其中，該第一伺服器計算出該等血糖值的一平均值，並根據該平均值計算出該醣化血色素估計值，其中該醣化血色素估計值正相關於該平均值。The physiological parameter monitoring system according to claim 3, wherein the first server calculates an average value of the blood glucose levels, and calculates the glycated hemoglobin estimation value according to the average value, wherein the glycated hemoglobin estimation value is positive Related to this average. 如請求項3所述的生理參數監測系統，其中，當該醣化血色素量測值與該醣化血色素估計值差距大於一門檻值時，該第一伺服器輸出一警示訊息。The physiological parameter monitoring system according to claim 3, wherein the first server outputs a warning message when the difference between the glycated hemoglobin measurement value and the glycated hemoglobin estimation value is greater than a threshold value. 如請求項2所述的生理參數監測系統，其中，該第二檢測裝置還產生一相關於該使用者的血糖值並將該血糖值傳送至該第一伺服器，且該第一伺服器還根據從該第一檢測裝置與該第二檢測裝置接收到的該等血糖值的其中多者計算出至少一統計量。The physiological parameter monitoring system of claim 2, wherein the second detecting device further generates a blood glucose value associated with the user and transmits the blood glucose value to the first server, and the first server further At least one statistic is calculated based on a plurality of the blood glucose values received from the first detecting device and the second detecting device. 如請求項9所述的生理參數監測系統，其中，該第一伺服器根據從該第一檢測裝置與該第二檢測裝置接收到的該等血糖值的其中多者計算出該多者的一平均值與一標準差，當該標準差大於該平均值的一第一倍數時，該第一伺服器還輸出一用於指示波動過大的資訊，當該標準差小於該平均值的一第二倍數時，該第一伺服器還輸出一用於指示波動理想的資訊，當該標準差大於該平均值的該第二倍數且小於該平均值的該第一倍數時，該第一伺服器還輸出一用於指示波動較大的資訊，其中該第一倍數大於該第二倍數。The physiological parameter monitoring system of claim 9, wherein the first server calculates one of the plurality of blood glucose values according to the plurality of blood glucose values received from the first detecting device and the second detecting device The average value is a standard deviation. When the standard deviation is greater than a first multiple of the average value, the first server further outputs a message for indicating excessive fluctuation, when the standard deviation is less than a second of the average value. When the multiple is used, the first server further outputs a message for indicating the ideal of the fluctuation. When the standard deviation is greater than the second multiple of the average value and less than the first multiple of the average value, the first server further Outputting a message for indicating a large fluctuation, wherein the first multiple is greater than the second multiple. 如請求項10所述的生理參數監測系統，該系統提供一視覺化圖表，該圖表有一橫軸用以表示該血糖值的複數個事件標籤、一縱軸用以表示該平均值與該標準差的數值、複數個平均值指示器以及複數個標準差指示器，其中該複數個平均值指示器指出該平均值的數值，該複數個標準差指示器指出該標準差的數值，該標準差指示器至少一部分位於該平均值指示器內。The physiological parameter monitoring system of claim 10, wherein the system provides a visualization chart having a horizontal axis for indicating a plurality of event labels of the blood glucose level, and a vertical axis for indicating the average value and the standard deviation a value, a plurality of average indicators, and a plurality of standard deviation indicators, wherein the plurality of average indicators indicate a value of the average, the plurality of standard deviation indicators indicating a value of the standard deviation, the standard deviation indication At least a portion of the device is located within the average indicator. 如請求項1所述的生理參數監測系統，其中，該第一檢測裝置包含一檢測單元及一行動裝置，該檢測單元產生該等第一生理參數，並藉由下列步驟傳送該等第一生理參數至該行動裝置: (a) 該行動裝置傳送一當地時間至該檢測單元，以致該行動裝置與該檢測單元在時間上同步； (b) 該檢測單元傳送該等第一生理參數與對應該等第一生理參數的複數個資料所形成的一數據序列至該行動裝置，其中該數據序列至少包含一量測時間；及 (c)該行動裝置儲存該數據序列及對應該量測時間的一世界標準時間。The physiological parameter monitoring system of claim 1, wherein the first detecting device comprises a detecting unit and a mobile device, the detecting unit generates the first physiological parameters, and transmits the first physiological components by the following steps Parameter to the mobile device: (a) the mobile device transmits a local time to the detecting unit such that the mobile device synchronizes with the detecting unit in time; (b) the detecting unit transmits the first physiological parameter and corresponds to And a data sequence formed by the plurality of data of the first physiological parameter to the mobile device, wherein the data sequence includes at least one measurement time; and (c) the mobile device stores the data sequence and one of the time corresponding to the measurement UTC. 如請求項12所述的生理參數監測系統，其中，在該步驟(c)，該行動裝置根據該世界標準時間排序該等第一生理參數。The physiological parameter monitoring system of claim 12, wherein, in the step (c), the mobile device sorts the first physiological parameters according to the world standard time.

• 2017
  • 2017-05-17 TW TW106116270A patent/TWI627940B/en active

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.4